Phase 4
Completed N=19
Effects of Lubiprostone on Gastric Function in Patients With Chronic Idiopathic Constipation
Chronic Idiopathic Constipation
Source: ClinicalTrials.gov NCT01460225 ↗
Enrolled (actual)
19
Serious AEs
0.0%
Results posted
Jul 2018
Primary outcomePrimary: Gastric Emptying — 0.27; 0.384; 0.04; 0.051 percent meal retention — p=0.003
◆ Published Evidence
No publication linked
No peer-reviewed publication reporting this trial's results has been linked yet. This can indicate results are unpublished — a known publication-bias signal. We re-check periodically.
Summary
This prospective study is designed to evaluate how lubiprostone may affect gastric motor and sensory function.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Gastric Emptying |
0.27; 0.384; 0.04; 0.051 | 0.003 sig |
Eligibility Criteria
Inclusion Criteria
- chronic idiopathic constipation
Exclusion Criteria
- medications that slow gastrointestinal (GI) motility
- prior surgery to the GI tract
Data sourced from ClinicalTrials.gov (NCT01460225). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.